Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-01-25 00:00:00 ET · period of report 2024-01-23 · accession 0001415889-24-001821 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-25 | 2024-01-23 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $63.92 | -15.0K | 377.9K | -4% | -$958.8K |
| DM | 2024-01-25 | 2024-01-23 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $1.44 | +15.0K | 378.8K | +4% | +$21.6K |
| DM | 2024-01-25 | 2024-01-23 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -15.0K | 105.2K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-23 | S | D | 2,938 | $63.22 | 387,876 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $62.625 to $63.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-01-23 | S | D | 2,039 | $64.78 | 375,814 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $64.70 to $64.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-01-23 | S | D | 10,023 | $63.95 | 377,853 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $63.66 to $64.625. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-01-23 | M | A | 12,000 | $1.79 | 390,814 | D | — | — | |
| 5 | Common | Common Stock | 2024-01-23 | M | A | 3,000 | $0.04 | 378,814 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-01-23 | M | D | 3,000 | $0.00 | 663 | D | $0.04 · — to 2025-04-23 | 3,000 Common Stock | (F7) Stock Option is fully vested and exercisable. |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-01-23 | M | D | 12,000 | $0.00 | 105,225 | D | $1.79 · — to 2027-05-17 | 12,000 Common Stock | (F7) Stock Option is fully vested and exercisable. |